zanzalintinib
XL092-009
Phase 1 small_molecule terminated
Quick answer
zanzalintinib for Advanced Clear Cell Renal Cell Carcinoma or Other Advanced Solid Tumors is a Phase 1 program (small_molecule) at Arcus Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arcus Biosciences
- Indication
- Advanced Clear Cell Renal Cell Carcinoma or Other Advanced Solid Tumors
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated